Sarah Cannon Research Institute
@scri.com
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development.
We’re expanding our collaboration with @bmsnews to accelerate cancer research and broaden access to clinical trials through SCRI’s Accelero model.
Read more: www.scri.com/news/sarah-c...
#CancerResearch #ClinicalTrials
Read more: www.scri.com/news/sarah-c...
#CancerResearch #ClinicalTrials
November 12, 2025 at 2:17 PM
We’re expanding our collaboration with @bmsnews to accelerate cancer research and broaden access to clinical trials through SCRI’s Accelero model.
Read more: www.scri.com/news/sarah-c...
#CancerResearch #ClinicalTrials
Read more: www.scri.com/news/sarah-c...
#CancerResearch #ClinicalTrials
November is #LungCancerAwarenessMonth.
#SCRI's Dr. Melissa Johnson joined NewsChannel 5 to discuss how early detection and clinical trials are transforming lung cancer care. From low-dose CT scans to bispecifics, the future of treatment is here.
www.newschannel5.com/news/let-me-...
#SCRI's Dr. Melissa Johnson joined NewsChannel 5 to discuss how early detection and clinical trials are transforming lung cancer care. From low-dose CT scans to bispecifics, the future of treatment is here.
www.newschannel5.com/news/let-me-...
November 7, 2025 at 5:59 PM
November is #LungCancerAwarenessMonth.
#SCRI's Dr. Melissa Johnson joined NewsChannel 5 to discuss how early detection and clinical trials are transforming lung cancer care. From low-dose CT scans to bispecifics, the future of treatment is here.
www.newschannel5.com/news/let-me-...
#SCRI's Dr. Melissa Johnson joined NewsChannel 5 to discuss how early detection and clinical trials are transforming lung cancer care. From low-dose CT scans to bispecifics, the future of treatment is here.
www.newschannel5.com/news/let-me-...
Your breast cancer risk is personal—and understanding it is powerful.
SCRI's Dr. Denise Yardley shares how genetic testing is changing prevention on @newschannel5plus.bsky.social .
🎥 Watch: bit.ly/DrYardleyBCAM
#BCAM #BreastCancerAwareness #EarlyDetection #SCRI
SCRI's Dr. Denise Yardley shares how genetic testing is changing prevention on @newschannel5plus.bsky.social .
🎥 Watch: bit.ly/DrYardleyBCAM
#BCAM #BreastCancerAwareness #EarlyDetection #SCRI
October 9, 2025 at 7:35 PM
Your breast cancer risk is personal—and understanding it is powerful.
SCRI's Dr. Denise Yardley shares how genetic testing is changing prevention on @newschannel5plus.bsky.social .
🎥 Watch: bit.ly/DrYardleyBCAM
#BCAM #BreastCancerAwareness #EarlyDetection #SCRI
SCRI's Dr. Denise Yardley shares how genetic testing is changing prevention on @newschannel5plus.bsky.social .
🎥 Watch: bit.ly/DrYardleyBCAM
#BCAM #BreastCancerAwareness #EarlyDetection #SCRI
We’re celebrating Dr. Howard “Skip” Burris’s remarkable career as he prepares to retire as President & CMO of SCRI.
His legacy: 850+ first-in-human trials, countless lives impacted. 💙
Welcome new leaders and read the full update:
www.scri.com/news/scri-an...
His legacy: 850+ first-in-human trials, countless lives impacted. 💙
Welcome new leaders and read the full update:
www.scri.com/news/scri-an...
October 6, 2025 at 6:08 PM
We’re celebrating Dr. Howard “Skip” Burris’s remarkable career as he prepares to retire as President & CMO of SCRI.
His legacy: 850+ first-in-human trials, countless lives impacted. 💙
Welcome new leaders and read the full update:
www.scri.com/news/scri-an...
His legacy: 850+ first-in-human trials, countless lives impacted. 💙
Welcome new leaders and read the full update:
www.scri.com/news/scri-an...
At 45, Bryan was diagnosed with advanced prostate cancer.
A BRCA mutation led him to a clinical trial through SCRI at Texas Oncology.
Today, his PSA levels are undetectable—and he’s thriving. 💙
#ProstateCancer #BRCA #SCRI #TexasOncology #USOncologyNetwork #ClinicalTrials #CancerResearch
A BRCA mutation led him to a clinical trial through SCRI at Texas Oncology.
Today, his PSA levels are undetectable—and he’s thriving. 💙
#ProstateCancer #BRCA #SCRI #TexasOncology #USOncologyNetwork #ClinicalTrials #CancerResearch
October 2, 2025 at 5:14 PM
At 45, Bryan was diagnosed with advanced prostate cancer.
A BRCA mutation led him to a clinical trial through SCRI at Texas Oncology.
Today, his PSA levels are undetectable—and he’s thriving. 💙
#ProstateCancer #BRCA #SCRI #TexasOncology #USOncologyNetwork #ClinicalTrials #CancerResearch
A BRCA mutation led him to a clinical trial through SCRI at Texas Oncology.
Today, his PSA levels are undetectable—and he’s thriving. 💙
#ProstateCancer #BRCA #SCRI #TexasOncology #USOncologyNetwork #ClinicalTrials #CancerResearch
💡 Why consider a clinical trial during your cancer journey?
✨ Access cutting-edge treatments
✨ Stay close to home
✨ Help shape the future of cancer care
🎥 Watch our latest video to learn more: www.scri.com/patients/
#CancerAwareness #ClinicalTrials #OncologyResearch #SCRI #HopeCloseToHome
✨ Access cutting-edge treatments
✨ Stay close to home
✨ Help shape the future of cancer care
🎥 Watch our latest video to learn more: www.scri.com/patients/
#CancerAwareness #ClinicalTrials #OncologyResearch #SCRI #HopeCloseToHome
July 30, 2025 at 6:50 PM
💡 Why consider a clinical trial during your cancer journey?
✨ Access cutting-edge treatments
✨ Stay close to home
✨ Help shape the future of cancer care
🎥 Watch our latest video to learn more: www.scri.com/patients/
#CancerAwareness #ClinicalTrials #OncologyResearch #SCRI #HopeCloseToHome
✨ Access cutting-edge treatments
✨ Stay close to home
✨ Help shape the future of cancer care
🎥 Watch our latest video to learn more: www.scri.com/patients/
#CancerAwareness #ClinicalTrials #OncologyResearch #SCRI #HopeCloseToHome
Thank you, #ASCO25!
We’re grateful to our presenters, panelists, and the entire ASCO community for an inspiring week of innovation and collaboration.
Here’s to advancing therapies for patients —together.
Until next year!
#SCRI #CancerResearch #OncologyLeadership #ThankYouASCO
We’re grateful to our presenters, panelists, and the entire ASCO community for an inspiring week of innovation and collaboration.
Here’s to advancing therapies for patients —together.
Until next year!
#SCRI #CancerResearch #OncologyLeadership #ThankYouASCO
June 5, 2025 at 3:18 PM
Thank you, #ASCO25!
We’re grateful to our presenters, panelists, and the entire ASCO community for an inspiring week of innovation and collaboration.
Here’s to advancing therapies for patients —together.
Until next year!
#SCRI #CancerResearch #OncologyLeadership #ThankYouASCO
We’re grateful to our presenters, panelists, and the entire ASCO community for an inspiring week of innovation and collaboration.
Here’s to advancing therapies for patients —together.
Until next year!
#SCRI #CancerResearch #OncologyLeadership #ThankYouASCO
We look forward to seeing more of you on day four of the #ASCO25 Annual Meeting. Stop by both #27022 to meet experts from across the network, from 9:45am-2:00pm. #CancerResearch uberflip.scri.com/i/1535506-me...
June 2, 2025 at 12:55 PM
We look forward to seeing more of you on day four of the #ASCO25 Annual Meeting. Stop by both #27022 to meet experts from across the network, from 9:45am-2:00pm. #CancerResearch uberflip.scri.com/i/1535506-me...